tetano
Editor, Senior Moderator
New Microbes New Infect. 2020 Apr 14;35:100680. doi: 10.1016/j.nmni.2020.100680. eCollection 2020 May.
Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19.
Saqrane S[SUP]1[/SUP], El Mhammedi MA[SUP]2[/SUP].
Author information
Abstract
Covid-19 disease is caused by SARS-CoV-2, a virus belonging to the coronavirus family. Covid-19 is so new that there is currently no specific vaccine or treatment. Clinical trials are currently underway. In vitro tests are also being conducted to assess the efficacy of chloroquine and hydroxychloroquine for the treatment of this epidemic, which is considered a pandemic by the WHO. We note that the content of this review is dated. The information it contains is subject to change and modification as the epidemic progresses.
? 2020 Published by Elsevier Ltd.
KEYWORDS:
Chloroquine; Covid-19; coronavirus; epidemic; hydroxychloroquine; treatment
PMID:32322402PMCID:PMC7171523DOI:10.1016/j.nmni.2020.100680
Review on the global epidemiological situation and the efficacy of chloroquine and hydroxychloroquine for the treatment of COVID-19.
Saqrane S[SUP]1[/SUP], El Mhammedi MA[SUP]2[/SUP].
Author information
Abstract
Covid-19 disease is caused by SARS-CoV-2, a virus belonging to the coronavirus family. Covid-19 is so new that there is currently no specific vaccine or treatment. Clinical trials are currently underway. In vitro tests are also being conducted to assess the efficacy of chloroquine and hydroxychloroquine for the treatment of this epidemic, which is considered a pandemic by the WHO. We note that the content of this review is dated. The information it contains is subject to change and modification as the epidemic progresses.
? 2020 Published by Elsevier Ltd.
KEYWORDS:
Chloroquine; Covid-19; coronavirus; epidemic; hydroxychloroquine; treatment
PMID:32322402PMCID:PMC7171523DOI:10.1016/j.nmni.2020.100680